99% Savings - Buy Just @1 Rs X
Swispas is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Abdominal Pain, Stomach Pain. Secondary and off-label uses of Swispas have also been mentioned below.
The optimal dosage of Swispas is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Common side effects of Swispas include Nausea or vomiting, Dry Mouth, Blurred vision. These side effects of Swispas are usually temporary and subside with the completion of treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Swispas's effect during pregnancy is Moderate and Moderate while nursing. Warnings related to Swispas's effects on the liver, heart and kidney, if any, have been listed below.
Swispas is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Stomach Disease, Alcoholism are examples of such conditions. Other conditions have been mentioned below in the Swispas contraindications section.
Besides this, Swispas may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Swispas, it is important to know that it is safe while driving, and is habit-forming.
Swispas is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Swispas safe for pregnant women?
Swispas may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Swispas again without your doctor's advice.
Is the use of Swispas safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Swispas. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Swispas on the Kidneys?
Kidney can be affected by Swispas. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Swispas on the Liver?
The liver can be affected by Swispas. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Swispas only after medical advice.
What is the effect of Swispas on the Heart?
In the absence of any scientific study on the side effects of Swispas on the heart, information on safety of Swispas for the heart is unavailable.
Swispas should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Swispas unless your doctor advises you to do so -
Is this Swispas habit forming or addictive?
No, there is no any evidence that Swispas is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Swispas will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Swispas should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Swispas is not used to treat mental disorders.
Interaction between Food and Swispas
Taking Swispas with food is safe.
Interaction between Alcohol and Swispas
Taking Swispas with alcohol can have severely harmful effects on your health.
Swispas is a carboxylic acid derivative with antispasmodic and anticholinergic activity. Swispas stops acetylcholine from binding to the muscarinic receptors on the smooth muscles, leading to the relaxation of smooth muscles of the gastrointestinal tract, and regulating bronchial, tracheal and pharyngeal secretions.
Yes, Swispas when used in combination with mefanamic acid can be used for the effective management of period pain or dysmenorrhea. Dysmenorrhea results from the excessive release of prostaglandins which decrease uterine blood flow, increase uterine contractions and also cause peripheral nerve hypersensitivity leading to the development of pain. Period pain can severely affect a person's quality of life. It can be prevented and managed by taking calcium and magnesium supplements as they help in muscle relaxation, cutting down on coffee, using a heating pad, taking light meals, taking herbal tea, eating a low fat diet, massaging with essential oils, practicing acupuncture and doing some mild physical activity.
Yes, it is safe to use Swispas under the guidance of a doctor.
No, Swispas does not cause weight gain. Weight gain can be prevented or managed by eating a low carb, high protein diet, incorporating some sort of physical activity in the lifestyle like yoga, zumba, pilates, aerobics, etc., drinking plenty of water, ensuring that the bowel moment is clear, drinking green tea, trying intermittent fasting, cutting back on dairy, gluten and added sugar, taking probiotics, eating more fiber, lifting weights, and eating more vegetables and fruits.
Yes, Swispas causes nausea and vomiting as side effects. Nausea and vomiting can be prevented and managed by trying deep breathing, trying wrist acupressure, being in well ventilated space, drinking more fluids, taking ginger, fennel or cloves, and trying aromatherapy.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bentyl (dicyclomine hydrochloride)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)